Transendocardial autologous cell therapy (hMSC or hBMC)

Autologous mesenchymal stem cells; autologous bone marrow cells · University of Miami

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Transendocardial autologous cell therapy (hMSC or hBMC), covering 2015-12-14 to 2015-12-14. Get the full timeline:

Most recent: Clinical Trial Update: The Transendocardial Autologous Cells (hMSC or hBMC) in Ischemic Heart Failure Trial (TAC-HFT) [Phase 1, Phase 2]

See pricing